Cobalt toxicity in humans- a review of the potential sources and systemic health effects
File(s)
Author(s)
Leyssens, L
Vinck, B
Van Der Straeten, C
Wuyts, F
Maes, L
Type
Journal Article
Abstract
Cobalt (Co) and its compounds are widely distributed in nature and are part of numerous anthropogenic activities. Although cobalt has a biologically necessary role as metal constituent of vitamin B12, excessive exposure has been shown to induce various adverse health effects. This review provides an extended overview of the possible Co sources and related intake routes, the detection and quantification methods for Co intake and the interpretation thereof, and the reported health effects. The Co sources were allocated to four exposure settings: occupational, environmental, dietary and medical exposure. Oral intake of Co supplements and internal exposure through metal-on-metal (MoM) hip implants deliver the highest systemic Co concentrations. The systemic health effects are characterized by a complex clinical syndrome, mainly including neurological (e.g. hearing and visual impairment), cardiovascular and endocrine deficits. Recently, a biokinetic model has been proposed to characterize the dose-response relationship and effects of chronic exposure. According to the model, health effects are unlikely to occur at blood Co concentrations under 300 μg/l (100 μg/l respecting a safety factor of 3) in healthy individuals, hematological and endocrine dysfunctions are the primary health endpoints, and chronic exposure to acceptable doses is not expected to pose considerable health hazards. However, toxic reactions at lower doses have been described in several cases of malfunctioning MoM hip implants, which may be explained by certain underlying pathologies that increase the individual susceptibility for Co-induced systemic toxicity. This may be associated with a decrease in Co bound to serum proteins and an increase in free ionic Co2+. As the latter is believed to be the primary toxic form, monitoring of the free fraction of Co2+ might be advisable for future risk assessment. Furthermore, future research should focus on longitudinal studies in the clinical setting of MoM hip implant patients to further elucidate the dose-response discrepancies.
Date Issued
2017-07-15
Date Acceptance
2017-05-24
Citation
Toxicology, 2017, 387, pp.43-56
ISSN
0300-483X
Publisher
Elsevier
Start Page
43
End Page
56
Journal / Book Title
Toxicology
Volume
387
Copyright Statement
© 2017 Elsevier B.V. All rights reserved. This manuscript is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International http://creativecommons.org/licenses/by-nc-nd/4.0/
Identifier
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000408072000005&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202
Subjects
Science & Technology
Life Sciences & Biomedicine
Pharmacology & Pharmacy
Toxicology
Cobalt
Systemic cobalt toxicity
Medical cobalt exposure
Dietary cobalt exposure
Occupational cobalt exposure
Metal-on-metal hip implants
TOTAL HIP-REPLACEMENT
ALLERGIC CONTACT-DERMATITIS
METAL-ION LEVELS
CELL INTERSTITIAL PNEUMONIA
WHOLE-BLOOD CONCENTRATIONS
BEER-DRINKERS MYOCARDOSIS
EXHALED BREATH CONDENSATE
SOLID-WASTE INCINERATION
HIGH-RESOLUTION CT
LUNG-DISEASE
Diet
Dietary Supplements
Dose-Response Relationship, Drug
Environmental Exposure
Environmental Monitoring
Environmental Pollutants
Hip Prosthesis
Humans
Metal-on-Metal Joint Prostheses
Occupational Exposure
Prosthesis Design
Risk Assessment
Toxicity Tests
1115 Pharmacology And Pharmaceutical Sciences
Publication Status
Published
Date Publish Online
2017-05-29